Application segmentation of the Cholangioscopic Direct Visualization System market isolates three primary use‑cases: diagnostic, therapeutic, and research. The diagnostic application encompasses procedures aimed at detecting biliary pathology, such as stone identification, tumor delineation, and stricture assessment. This segment commands the largest share—approximately 45 % of total revenue—driven by the growing prevalence of cholangiocarcinoma and the need for high‑resolution imaging in early‑stage detection. The therapeutic application includes interventions that rely on direct visualization to guide stone extraction, laser lithotripsy, and targeted biopsies; it contributes roughly 40 % of market size, reflecting rising procedural volumes in minimally invasive endoscopy. The research application, while smaller at about 15 % of market value, supports clinical trials and device development, influencing future adoption patterns. Collectively, these application categories define the overall Cholangioscopic Direct Visualization System segmentation and determine investment priorities across hospitals, specialty clinics, and academic centers. The diagnostic segment is projected to grow at a CAGR of 7 % through 2032, outpacing the therapeutic and research segments, which are expected to expand at 5 % and 4 % respectively.
